PUBLISHER: The Business Research Company | PRODUCT CODE: 2111278
PUBLISHER: The Business Research Company | PRODUCT CODE: 2111278
An artificial intelligence (AI)-powered personalized nutrition and metabolomics platforms are integrated healthcare and wellness solutions that utilize artificial intelligence to evaluate metabolomic, genetic, lifestyle, and dietary information for delivering customized nutritional recommendations. Metabolomics involves the study of small molecules and metabolic changes within the body to better understand an individual's health condition and nutritional requirements. These platforms leverage machine learning and advanced analytics to identify metabolic patterns, detect nutrient deficiencies, and assess potential health risks.
The primary platform types of artificial intelligence (AI)-powered personalized nutrition and metabolomics platform include artificial intelligence diet recommendation engine, metabolomics analytics platform, microbiome analysis platform, personalized supplement platform, digital nutrition dashboard, wearable health integration platform, and at home testing platform. Artificial intelligence diet recommendation engine refers to a platform that uses AI algorithms to evaluate individual health, dietary, and metabolic data to deliver personalized nutrition recommendations. These platforms are deployed through cloud-based artificial intelligence solutions and mobile app-first platforms, hybrid platforms integrating devices, applications, and subscriptions, and on-premise or enterprise-hosted artificial intelligence platforms for institutions and are used by end users including health-conscious consumers, athletes and fitness users, healthcare providers, corporate wellness programs, research institutions, nutritionists, and dietitians.
Tariffs are influencing the AI-powered personalized nutrition and metabolomics platforms market by increasing the cost of imported advanced diagnostic kits, biosensors, wearable devices, and laboratory sequencing equipment required for metabolic and genetic analysis. This is disrupting global supply chains and slowing adoption of at-home testing kits and wearable-integrated nutrition platforms, particularly in regions dependent on imported biotech and semiconductor-enabled health devices such as Asia-Pacific and North America. Segments such as metabolomics analytics platforms and microbiome testing kits are most affected due to their reliance on specialized laboratory infrastructure and reagents. However, tariffs are also encouraging localized production of diagnostic tools, regional biotech manufacturing expansion, and innovation in software-driven nutrition analytics, supporting long-term market resilience.
The artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market size has grown rapidly in recent years. It will grow from $1.69 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 19.7%. The growth in the historic period can be attributed to rising prevalence of lifestyle diseases such as obesity and diabetes, growing awareness of preventive healthcare and nutrition management, increasing adoption of basic dietary tracking applications, expansion of fitness and wellness industry globally, development of early nutrigenomics research and metabolic health studies.
The artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market size is expected to see rapid growth in the next few years. It will grow to $4.1 billion in 2030 at a compound annual growth rate (CAGR) of 19.3%. The growth in the forecast period can be attributed to advancement in ai-driven predictive health and nutrition analytics, expansion of precision medicine and personalized healthcare ecosystems, increasing adoption of wearable biosensors and continuous health monitoring, growth in consumer demand for customized wellness and diet solutions, rising integration of multi-omics data for holistic health optimization. Major trends in the forecast period include increasing adoption of ai-driven personalized nutrition platforms for metabolic health optimization, growing use of metabolomics-based diagnostics for precision dietary recommendations, rising integration of wearable health data into personalized nutrition ecosystems, expansion of microbiome-based nutrition planning and gut health optimization solutions, increasing demand for at-home genetic and metabolic testing kits for customized diet planning.
The increasing prevalence of lifestyle diseases is expected to propel the growth of the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market going forward. Lifestyle diseases refer to chronic health conditions primarily associated with unhealthy habits, including poor diet, physical inactivity, stress, inadequate sleep, and sedentary lifestyles. The increasing prevalence of lifestyle diseases is driven by sedentary lifestyles, as prolonged sitting, reduced physical activity, and increased screen time contribute to obesity, cardiovascular diseases, diabetes, and other chronic health conditions. Artificial intelligence (AI)-powered personalized nutrition and metabolomics platforms help address lifestyle diseases by analyzing metabolomic, genetic, dietary, and lifestyle data to provide personalized nutrition recommendations, support early disease risk detection, and improve preventive health management. For instance, in May 2025, according to the Office for Health Improvement and Disparities (OHID), a UK-based government public health organization, between 2023 and 2024, an estimated 64.5% of adults aged 18 years and older in England were classified as overweight or obese. Therefore, the increasing prevalence of lifestyle diseases is driving the growth of the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market.
Leading companies operating in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market are focusing on developing innovative products, such as AI-powered RNA-driven molecular diagnostics and precision nutrition platforms, to enhance personalized dietary recommendations, biological health tracking, and preventive healthcare management. AI-powered RNA-driven molecular diagnostics and precision nutrition platforms are advanced health intelligence systems that use RNA sequencing, artificial intelligence, and molecular analytics to assess active gene expression, generate personalized nutrition guidance, and provide actionable insights for improving metabolic health and disease prevention. For example, in April 2025, Viome Life Sciences Inc., a US-based biotechnology company, launched the AI-powered Full Body Intelligence Test to help individuals stay healthy, slow aging, and improve long-term wellness outcomes. The platform utilizes advanced RNA sequencing and artificial intelligence to decode the body's active gene expression and translate biological data into personalized daily health recommendations, including foods to eat, foods to avoid, and insights into connections between nutrition and common diseases. It also enables users to monitor and optimize health outcomes through evolving biological insights and precision nutrition guidance.
In May 2023, Thorne HealthTech Inc., a US-based wellness company, partnered with Arome Science to develop an advanced next-generation metabolomics testing platform. Through this partnership, the companies aim to develop a metabolomics test designed to enable personalized health and wellness insights for future consumer use. It combines metabolomics profiling with at-home biological sampling through the OneDraw device and data-driven interpretation within Thorne's AI-enabled health ecosystem. Arome Science is a US-based metabolomics and mass spectrometry services company.
Major companies operating in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market are Lumen.me Ltd.; ZOE Limited; Metabolon Inc.; Viome Life Sciences Inc.; Digbi Health Inc.; Lifesum AB; Levels Health Inc.; January AI Inc.; Heali AI Inc.; GenoPalate Inc.; Sun Genomics Inc.; Nutrigenetix LLC; Genetic Analysis AS; FoodMarble Digestive Health Limited; BiomeSense Inc.; Biolytica NDT AG; NutriSense Inc.; Season Health Inc.; Noom Inc.; Foodvisor; Nutrola; Samsung Food
North America was the largest region in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market includes revenues earned by entities by providing services such as metabolomic data analysis, artificial intelligence-based nutrition assessment, personalized meal planning, dietary recommendation management, health risk prediction, wellness monitoring, and cloud-based health analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market statistics, including artificial intelligence (AI)-powered personalized nutrition and metabolomics platform industry global market size, regional shares, competitors with a artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market share, detailed artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI)-powered personalized nutrition and metabolomics platform industry. This artificial intelligence (AI)-powered personalized nutrition and metabolomics platform market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial Intelligence (AI)-Powered Personalized Nutrition And Metabolomics Platform Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial intelligence (ai)-powered personalized nutrition and metabolomics platform market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial intelligence (ai)-powered personalized nutrition and metabolomics platform ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial intelligence (ai)-powered personalized nutrition and metabolomics platform market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.